The evolution of the role of radiation therapy in the management of mucocutaneous malignant melanoma.
The role of radiation therapy in the treatment of malignant melanoma has evolved substantially over time. Years ago, malignant melanomas were generally considered radioresistant. Over time, the palliative value of radiation therapy was established. Most recently it also has become clear that judiciously applied therapy may be curative in either an adjuvant setting or for small-volume disease.
Cooper
J S
JS
Department of Radiation Oncology, New York University Medical Center, New York, USA.
D000277:Adjuvants, Pharmaceutic / Q000627:therapeutic use; D006801:Humans; D008545:Melanoma / Q000473:pathology / Q000503:physiopathology / Q000532:radiotherapy*; D011836:Radiation Tolerance; D011879:Radiotherapy Dosage; D012878:Skin Neoplasms / Q000473:pathology / Q000503:physiopathology / Q000532:radiotherapy*
D000277:Adjuvants, Pharmaceutic